Related references
Note: Only part of the references are listed.Selective deletion of antigen-specific CD8+ T cells by MHC class I tetramers, coupled to the type I ribosome-inactivating protein saporin
Paul R. Hess et al.
BLOOD (2007)
Membrane-bound CD95 ligand expressed on human antigen-presenting cells prevents alloantigen-specific T cell response without impairment of viral and third-party T cell immunity
G. Strauss et al.
CELL DEATH AND DIFFERENTIATION (2007)
Antigen recognition induces phosphatidylserine exposure on the cell surface of human CD8+ T cells
Karin Fischer et al.
BLOOD (2006)
TNF receptor superfamily-induced cell death: redox-dependent execution
Han-Ming Shen et al.
FASEB JOURNAL (2006)
Autoimmunity in the era of genomics and proteomics
Alon Y. Hershko et al.
AUTOIMMUNITY REVIEWS (2006)
Autoreactive CD8 T cells associated with β cell destruction in type 1 diabetes
GGM Pinkse et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
CD8+ T cell-mediated HLA-A*0201-restricted cytotoxicity to transaldolase peptide 168-176 in patients with multiple sclerosis
B Niland et al.
JOURNAL OF IMMUNOLOGY (2005)
How do CD4+CD25+ regulatory T cells control autoimmunity?
JA Bluestone et al.
CURRENT OPINION IN IMMUNOLOGY (2005)
Tumor counterattack: fact or fiction?
FH Igney et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients
A Toma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Dendritic cell maturation by innate lymphocytes:: coordinated stimulation of innate and adaptive immunity
C Münz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Organ transplantation - how much of the promise has been realized?
RI Lechler et al.
NATURE MEDICINE (2005)
Induction of tolerance using Fas ligand: a double-edged immunomodulator
N Askenasy et al.
BLOOD (2005)
Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis
YCQ Zang et al.
JOURNAL OF IMMUNOLOGY (2004)
Dendritic cells overexpressing Fas-ligand induce pulmonary vasculitis in mice
S Buonocore et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Elimination of activated but not resting primary human CD4(+) and CD8(+) T cells by Fas ligand (FasL/CD95L)-expressing Killer-dendritic cells
S Hoves et al.
IMMUNOBIOLOGY (2004)
Targeted deletion of T-cell clones using alpha-emitting suicide MHC tetramers
RR Yuan et al.
BLOOD (2004)
Sensitive and viable identification of antigen-specific CD8+T cells by a flow cytometric assay for degranulation
MR Betts et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
The flow cytometric PKH-26 assay for the determination of T-cell mediated cytotoxic activity
K Fischer et al.
METHODS (2003)
CTLA-4 • FasL induces alloantigen-specific hyporesponsiveness
MD Elhalel et al.
JOURNAL OF IMMUNOLOGY (2003)
Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC
S Hoves et al.
JOURNAL OF IMMUNOLOGY (2003)
Tolerance induction in clinical transplantation: The pending questions
M Toungouz et al.
TRANSPLANTATION (2003)
Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells
M Oelke et al.
NATURE MEDICINE (2003)
Dendritic cells overexpressing CD95 (Fas) ligand elicit vigorous allospecific T-cell responses in vivo
S Buonocore et al.
BLOOD (2003)
In vivo augmentation of tumor-specific CTL responses by class I/peptide antigen complexes on microspheres (large multivalent immunogen)
J Goldberg et al.
JOURNAL OF IMMUNOLOGY (2003)
Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection
ES Yolcu et al.
IMMUNITY (2002)
Reduction of antiviral CD8 lymphocytes in vivo with dendritic cells expressing Fas ligand - Increased survival of viral (lymphocytic choriomeningitis virus) central nervous system infection
T Wolfe et al.
JOURNAL OF IMMUNOLOGY (2002)
Transduction of donor hematopoietic stem-progenitor cells with Fas ligand enhanced short-term engraftment in a murine model of allogeneic bone marrow transplantation
KA Whartenby et al.
BLOOD (2002)
Epitope spreading in immunemediated diseases: Implications for immunotherapy
CL Vanderlugt et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Immunosuppressive properties of CD95L-transduced killer hybrids created by fusing donor- and recipient-derived dendritic cells
H Matsue et al.
BLOOD (2001)
Specific immunotherapy by genetically engineered APCs: The guided missile strategy
B Wu et al.
JOURNAL OF IMMUNOLOGY (2001)
CTLA-4-Fas ligand functions as a trans signal converter protein in bridging antigen-presenting cells and T cells
JH Huang et al.
INTERNATIONAL IMMUNOLOGY (2001)
CD95's deadly mission in the immune system
PH Krammer
NATURE (2000)
Antigen-specific induction of peripheral T cell tolerance in vivo by codelivery of DNA vectors encoding antigen and Fas ligand
RW Georgantas et al.
HUMAN GENE THERAPY (2000)
CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity
IF Hermans et al.
JOURNAL OF IMMUNOLOGY (2000)
Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival
WP Min et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
